Eli Lilly and Company +

Eli Lilly and Company

Company

Ticker

LLY

JNJ

ABBV

MRK

Headquarter

Indianapolis ,IN

New Brunswick ,NJ

North Chicago ,IL

Rahway ,NJ

CEO

David A. Ricks

Joaquin Duato

Scott T. Reents

Robert Davis

Industry

Drug Manufacturers - General

Stock Price

Market Cap

$992.60 B

$598.69 B

$410.09 B

$309.18 B

Employees

Years

2024
2025
2026

2024
2025
2026

2024
2025
2026

2024
2025
2026

Employees

43.00 K
47.00 K
200.00 K

131.90 K
138.10 K
138.20 K

50.00 K
55.00 K
57.00 K

72.00 K
75.00 K
75.00 K

Y/Y

10.26%

9.3%

325.53%

13.62%

4.7%

0.07%

10%

3.64%

4.35%

4.17%

Income Statement

Revenue

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Revenue

$34.12 B
$45.04 B
$65.18 B

$85.16 B
$88.82 B
$94.19 B

$54.32 B
$56.33 B
$61.16 B

$60.12 B
$64.17 B
$65.01 B

Y/Y

19.56%

32%

44.7%

6.46%

4.3%

6.05%

6.44%

3.71%

8.57%

1.4%

6.74%

1.31%

Revenue by Products / Services

Years

2025

2025

2025

2025

Revenue by Geography

Years

2025

2025

2025

2025

Research and Development

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Research and Development

$9.31 B
$10.99 B
$13.34 B

$15.09 B
$17.23 B
$14.67 B

$7.68 B
$12.79 B
$9.10 B

$30.53 B
$17.94 B
$15.60 B

Y/Y

29.52%

18.01%

21.35%

6.72%

14.23%

14.9%

17.9%

66.66%

28.89%

125.35%

41.25%

13.06%

Operating Income

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Operating Income

$10.79 B
$17.50 B
$29.70 B

$23.41 B
$22.15 B
$25.60 B

$12.76 B
$9.14 B
$21.21 B

$2.95 B
$20.22 B
$26.78 B

Y/Y

24.66%

62.24%

69.67%

11.4%

5.38%

15.56%

29.59%

28.38%

132.18%

83.84%

584.53%

32.43%

Tax Rate (%)

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Tax Rate (%)

20.05%
16.49%
19.79%

11.53%
15.71%
17.73%

22.03%
-15.34%
35.83%

80.04%
14.06%
13.31%

Y/Y

143%

17.78%

20.04%

25.35%

36.28%

12.89%

81.94%

169.62%

333.62%

586.24%

82.43%

5.33%

Net Income

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Net Income

$5.24 B
$10.59 B
$20.64 B

$35.15 B
$14.07 B
$26.80 B

$4.86 B
$4.28 B
$4.23 B

$365.00 M
$17.12 B
$18.25 B

Y/Y

16.08%

102.08%

94.88%

95.94%

59.99%

90.56%

58.91%

12.03%

1.22%

97.49%

4589.59%

6.64%

Revenue Per Employee

Years

2024
2025
2026

2024
2025
2026

2024
2025
2026

2024
2025
2026

Revenue Per Employee

$1.05 M
$1.39 M
-

$673.40 K
$682.06 K
-

$1.13 M
$1.11 M
-

$891.22 K
$866.81 K
-

Y/Y

19.72%

32.39%

100%

20.75%

1.29%

100%

3.71%

1.3%

100%

2.29%

2.74%

100%

Net Income Per Employee

Years

2024
2025
2026

2024
2025
2026

2024
2025
2026

2024
2025
2026

Net Income Per Employee

$246.28 K
$439.11 K
-

$106.64 K
$194.09 K
-

$85.56 K
$76.84 K
-

$237.74 K
$243.39 K
-

Y/Y

83.29%

78.3%

100%

53.68%

82%

100%

12.03%

10.2%

100%

4394.19%

2.38%

100%

Assets & Liabilities | Cash Flow

Total Assets

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Total Assets

$64.01 B
$78.71 B
$112.48 B

$167.56 B
$180.10 B
$199.21 B

$134.71 B
$135.16 B
$5.46 B

$106.68 B
$117.11 B
-

Y/Y

29.33%

22.98%

42.89%

10.58%

7.49%

10.61%

2.95%

0.33%

95.96%

2.28%

9.78%

100%

Total Liabilities

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Total Liabilities

$53.14 B
$64.44 B
$85.94 B

$98.78 B
$108.61 B
$117.67 B

$124.31 B
$131.80 B
$26.29 B

$69.04 B
$70.73 B
-$51.91 B

Y/Y

37.27%

21.26%

33.36%

10.66%

9.95%

8.33%

2.3%

6.02%

80.05%

9.41%

2.45%

173.38%

Capital Expenditures (Capex)

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Capital Expenditures (Capex)

-$7.39 B
-$8.40 B
-$7.84 B

-$4.54 B
-$4.42 B
-$4.83 B

-$777.00 M
-$974.00 M
-

-$3.86 B
-$3.37 B
-

Y/Y

147.62%

13.68%

6.69%

13.32%

2.62%

9.22%

11.8%

25.35%

100%

11.96%

12.71%

100%

Profitability

Operating Income Margin (%)

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Operating Income Margin (%)

31.61%
38.86%
45.56%

27.49%
24.94%
27.17%

23.49%
16.22%
34.69%

4.91%
31.51%
41.19%

Y/Y

4.27%

22.91%

17.26%

4.64%

9.28%

8.97%

24.74%

30.94%

113.86%

84.07%

541.29%

30.71%

Net Income Margin (%)

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Net Income Margin (%)

15.36%
23.51%
31.66%

41.28%
15.84%
28.46%

8.95%
7.59%
6.91%

0.61%
26.68%
28.08%

Y/Y

29.81%

53.1%

34.68%

84.04%

61.64%

79.69%

56.09%

15.18%

9.01%

97.52%

4293.38%

5.26%

EBITDA

2022	8660500000.00
2023	8567800000.00
2024	15227600000.00
2025	27936500000.00

2022	26605000000.00
2023	23320000000.00
2024	24781000000.00
2025	32581000000.00

2022	24174000000.00
2023	17172000000.00
2024	14910000000.00
2025	28293665000.00

2022	21315000000.00
2023	6907000000.00
2024	25706000000.00
2025	25360332000.00

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

EBITDA

$8.57 B
$15.23 B
$27.94 B

$23.32 B
$24.78 B
$32.58 B

$17.17 B
$14.91 B
$28.29 B

$6.91 B
$25.71 B
$25.36 B

Y/Y

1.07%

77.73%

83.46%

12.35%

6.27%

31.48%

28.97%

13.17%

89.76%

67.6%

272.17%

1.34%

Free Cash Flow (FCF)

2022	4600400000.00
2023	-3152000000.00
2024	414300000.00
2025	8972000000.00

2022	17185000000.00
2023	18248000000.00
2024	19842000000.00
2025	19698000000.00

2022	24248000000.00
2023	22062000000.00
2024	17832000000.00
2025	0.00

2022	14707000000.00
2023	9143000000.00
2024	18096000000.00
2025	0.00

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Free Cash Flow (FCF)

-$3.15 B
$414.30 M
$8.97 B

$18.25 B
$19.84 B
$19.70 B

$22.06 B
$17.83 B
-

$9.14 B
$18.10 B
-

Y/Y

168.52%

113.14%

2065.58%

6.19%

8.74%

0.73%

9.02%

19.17%

100%

37.83%

97.92%

100%

Ratios

Return on Equity (ROE)

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Return on Equity (ROE)

48.65%
74.62%
0.00%

51.11%
19.68%
0.00%

46.94%
128.66%
0.00%

0.97%
36.96%
35.17%

Y/Y

17.03%

53.38%

100%

118.81%

61.51%

100%

31.57%

174.1%

100%

96.92%

3705.4%

4.85%

Return on Assets (ROA)

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Return on Assets (ROA)

8.19%
13.45%
0.00%

20.98%
7.81%
0.00%

3.61%
3.17%
0.00%

0.34%
14.62%
0.00%

Y/Y

35.12%

64.32%

100%

119.11%

62.77%

100%

57.66%

12.32%

100%

97.43%

4171.87%

100%

Debt to Equity

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Debt to Equity

234.18%
237.06%
160.18%

42.65%
51.24%
58.78%

580.31%
2,040.33%
-2,112.17%

96.51%
82.63%
93.79%

Y/Y

53.58%

1.23%

32.43%

17.37%

20.15%

14.71%

55.98%

251.59%

203.52%

38.77%

14.38%

13.5%

Valuation

Enterprise Value

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Enterprise value

$546.67 B
$725.64 B
$0.00

$404.57 B
$358.79 B
$0.00

$321.29 B
$376.67 B
$0.00

$313.66 B
$276.91 B
$263.93 B

Y/Y

51.1%

32.74%

100%

17.17%

11.32%

100%

5.83%

17.24%

100%

4.48%

11.72%

4.69%

Enterprise value to Revenue

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Enterprise value to Revenue

16.02
16.11
0.00

4.75
4.04
0.00

5.92
6.69
0.00

5.22
4.32
4.06

Y/Y

26.38%

0.56%

100%

22.2%

14.97%

100%

0.64%

13.04%

100%

3.03%

17.29%

5.92%

Enterprise value to EBITDA

Years

2023
2024
2025

2023
2024
2025

2023
2024
2025

2023
2024
2025

Enterprise value to EBITDA

63.81
47.65
0.00

17.35
14.48
0.00

18.71
25.26
0.00

45.41
10.77
12.53

Y/Y

52.74%

25.31%

100%

5.5%

16.54%

100%

32.56%

35.02%

100%

222.42%

76.28%

16.3%

Eli Lilly and Company Competitors & Alternatives

Income Statement

Assets & Liabilities | Cash Flow

Profitability

Ratios

Valuation

Related company

Submit feedback to Bullfincher